Zurita Laboratorio Farmaceutico Ltda. Report issue

For profit Phase 3 Phase 4
Founded: Araras Brazil (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2009
NCT00877409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

benzoyl peroxide (clearasil) (2 trials)

sulfur (2 trials)

Drugs in Phase 3 Trials (2)

luffa operculate (1 trial)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Nasal Obstruction (Phase 3)

Rhinitis (Phase 3)

Sinusitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4